Abstract
toxins such as potassium and phosphate, which differ in 4-hourly samples (0-60, 61-120, 121-180 and from urea in their distribution and elimination charac-181-240 min). Plasma potassium (PK ) and blood urea were teristics. Therefore, we undertook a similar study in also measured at the beginning, at hourly intervals, and at our dialysis population using treatment modalities the end of the dialysis procedure. Blood samples were drawn typical of our dialysis unit (high-flux, glucose-free, from the arteriovenous fistula at the beginning and at the 40 mmol/l bicarbonate HD) and investigated the effect end of HD. Blood sampling at the end of HD was performed of 0K, 1K, and 2K baths on urea and potassium 5 min after the completion of treatment to avoid vascular elimination.
access and cardiopulmonary recirculations following the recommendations of the NKF-DOQI Clinical Practice Guidelines for Haemodialysis Adequacy [11] . During the dialysis procedure, samples were taken from the arterial line.
Subjects and methods
Efficiency of HD for urea and potassium was determined by clearance ( Kd) based on dialysate and ultrafiltrate Patients collection, urea reduction ratio ( URR) and Kt/V.
Twelve patients with end-stage renal disease receiving mainBiochemistry tenance high-flux HD were studied prospectively. There were six women and six men aged 30-73 (56.2±4.1 mean±SEM ) Potassium was measured using an IMT-Modul on a years. Six patients suffered from chronic glomerulonephritis, Dimension RXL (DADE-Behring, Marburg, Germany) in three from analgesic nephropathy, and one each from adult heparin-plasma and dialysate. Coefficients of variation were polycystic kidney disease, nephrosclerosis, and reflux nephroless than 2%. Urea was measured in heparin-plasma and pathy respectively. Diabetic patients and those with heart dialysate according to the urease-glutamate-dehydrogenase disease were not considered for this study. Six patients had technique on the Dimension RLX. Coefficients of variations radiocephalic fistulae, five had brachiocephalic fistulae, and were less than 2.5%. one had a brachiosubclavian PTFE graft. Serum albumin of all patients was above 35 (mean 41.1±1.2) g/l and the mean predialysis haematocrit was 38.0±1.0% at the beginning of Analysis the study. Patients were studied under their normal every day condition; for this reason food was allowed as usual. All Total dialysate plus ultrafiltrate volume ( Vd, in l ) was patients continued to receive their normal medication. One calculated from the volume ( Vc) obtained from partial patient received a small dose of the cardioselective b-blocker dialysate and ultrafiltrate collections and from the calibration atenolol (50 mg day) and two received amlodipine (5-10 mg factor (f ) determined at the beginning of each study. Mass day) for treatment of hypertension, but none was taking of potassium and urea removed (M K , M U ) was calculated digoxin, angiotensin-converting enzyme inhibitors, angio-from the mean solute concentration in the collected dialysate tensin-receptor blockers, or potassium-binding exchange and from Vd. resins. Medications were not modified during the entire Dialyser urea clearance ( Kd U ) was calculated from the study period.
amount of solute removed and the area under the curve (AUC ) of the blood urea concentrations. Single pool Kt/V (Kt/Vsp) was calculated using the
Study design
second-generation formula of Daugirdas [12] . Kt/V measures the quantity of clearance normalized to distribution volume This was a randomized, cross-over, prospective clinical trial.
received by a patient. Kt/V has an exact physical meaning Patients were investigated during three 1-week standardized only with the single-pool constant volume urea kinetic model high-flux HD periods, using dialysates without potassium [13] . The relationship does not appear in more advanced (0K ), and dialysates containing 1 (1K ) and 2 (2K ) mmol/l models where volume ( V ) changes because of ultrafiltration of potassium. They were randomly assigned to the different and where urea transfer between peripheral and central body 1-week study treatments. During the entire study they were compartments is limited to tissue perfusion. An equilibrated treated with high-flux HD using a polysulphone filter (HF80, Kt/V can still be calculated either when an equilibrated postFresenius AG, Bad Homburg, Germany). HD was performed dialysis urea concentration is available or when the magnithrice weekly, at an effective blood flow rate of 300 ml/min tude of post-dialysis urea rebound can be predicted. However, corrected for pre-pump blood pressure and a dialysate flow the prediction of post-dialysis urea rebound and equilibrated of approximately 500 ml/min. Treatment time was 240 min.
Kt/V becomes unreliable when changes in regional perfusion Ultra-pure, bicarbonate-buffered dialysate with Na 140.0, are expected. Therefore a different approach was used to HCO 3 40.0, Mg2+ 0.5, and Ca2+ 1.5 mmol/l was obtained analyse the effect of dialysate potassium on dose of dialysis. by filtration through a 1.8 m2 polysulphone filter (Diasafe, The single-pool constant volume relationship between for Fresenius AG, Bad Homburg, Germany). The dialysate did Kt/V can be rearranged in terms of mass balances according not contain glucose. The same two dialysis monitors were to the following relationship: applied for all patients and filter reuse was not practised. The ultrafiltration rates were prescribed according to the Kt/V=−ln
(1) clinical needs and were calculated from the patient's net weight changes.
Potassium and urea kinetic investigations were performed where M 0 and M d refer to the mass of urea at the beginning of dialysis and to the mass of urea removed during dialysis during the mid-week treatment. Potassium and urea removal was measured by partial dialysate and ultrafiltrate collection respectively. Therefore Kt/V also measures the amount of solute remaining in the patient at the end of dialysis as described previously [8] [9] [10] . The collection system was calibrated before each study. The mean ratio (f=Vd/Vc) of (M 0 −M d ) relative to the amount of solute (M 0 ) present in the patient at the beginning of the treatment. Using this total dialysate volume ( Vd ) to collected volume ( Vc) was definition, mass balance can be used to determine an equilib-Potassium removal rated Kt/V (Kt/V e ) obtained under more realistic variable Figure 1 illustrates the effect of each dialysate potasvolume and two-pool conditions. It follows from Eq. 1 that sium concentration on plasma potassium concentration the difference in Kt/V e (DKt/V e ) delivered by two different and on hourly potassium removal. Predialysis plasma treatment modes A and B is given as potassium concentrations were only slightly lower with 0K and 1K dialysis treatments compared to 2K sium plasma concentrations (R2=0.18) ( Table 2) .
If a given variable showed significant heterogeneity across the three groups of dialysis in the preceding analysis of Urea removal variance, the differences between any two of the three groups were assessed with two-sided paired t-tests. Applying Urea removal is summarized in Figure 2 . Blood urea Bonferroni correction, the resulting P-values were multiplied and hourly urea removal followed an exponential by 3.
function, differing clearly from the potassium eliminaStepwise multiple linear regression analysis was performed tion pattern. In contrast to potassium kinetics, the using the blood and plasma levels of urea and potassium multiple regression between predicted urea removal respectively, to predict the mass of urea and potassium modelled from blood concentrations almost perfectly 
Results
potassium removal and total urea removal could be demonstrated (Figure 4) . Correspondingly, urea clearance was not influenced by the potassium content in All patients completed the study. The three 1-week periods were perfectly comparable. Predialysis weight, the dialysate. Kd U was 206.1±3.0, 211.1±3.5 and 211.5±2.9 mL/min during 0K, 1K and 2K (NS) dialysate flow, ultrafiltrate flow, and ultrafiltration volume were not different during 0K, 1K, and 2K respectively. Dialysis efficiency evaluated by URR and single treatments. Initial blood urea concentration, total body water and urea mass of the patients were not different pool Kt/V was not modified by using 0, 1 or 2 mmol/l of potassium in the dialysate. URR was 75±2% with during the study HDs as well (Table 1) . The three high-flux study HDs were comparable. 0K was dialysis without potassium in the dialysate, 1K was dialysis with 1 mmol/l, and 2K with 2 mmol/l potassium in the dialysate. Treatment time was 240 min and effective blood flow (Qb) was 300 ml/min. Values are means±SEM. Table generated from Stata using potassium removed as an outcome variable and the serum values. cb 0 , plasma potassium at beginning of HD; cb60, plasma potassium 60 min after initiation of HD; cb120, plasma potassium 120 min after initiation of HD; cb180, plasma potassium 180 min after initiation of HD; cbf, plasma potassium 5 min after end of HD, as predictor variables. The model described here using potassium plasma values does not predict potassium removal. Reduction of factors using likelihood ratio analysis does not show a contribution of single potassium values estimating potassium mass removal. prospective study showing that dialysis using lowpotassium dialysate baths did not affect the removal of urea in a group of stable, non-diabetic HD patients without heart disease treated with high-flux dialysers. 0K, 76±2% with 1K, and 75±2% with 2K (NS ). Single-pool Kt/V assessed by blood urea kinetic was This result is in striking contrast to an earlier report by Dolson et al. [7] who observed that a 1K dialysate 1.73±0.12 for 0K, 1.74±0.10 for 1K, and 1.67±0.10 for 2K (NS ). Initial body urea content was not differ-bath significantly reduced dialysis efficiency as measured by urea kinetics when compared to a 3K dialysate ent between treatments ( Table 1) . The difference in equilibrated Kt/V (DKtV e ) as determined from eq. 2 bath. It was not our aim to challenge the results reported by Dolson and Adrogué but to show that in was 0.08±0.05 and 0.11±0.05 units, and not different from zero when treatments using 1K and 2K dialysate a usual setting at our unit, using low-potassium dialysate did not affect dialysis efficiency as measured by baths were compared to potassium-free treatment modes respectively (one sample sign test, one sample urea kinetic analysis.
Is there an explanation for these findings? t-test). Table generated from Stata using potassium removed as an outcome variable and the serum values. cb60, blood urea 60 min after Fig. 4 . Correlation urea and potassium removal. Absence of correlainitiation of HD; cb120, blood urea 120 min after initiation of HD. tion between potassium removal (M K ) and urea removal (M U ) The model described here using values of blood urea does predict (r=0.22). urea removal precisely. Urea removal is therefore highly predicted using blood urea values of the first and second hour after initiation of HD. even more sequestered into the intracellular compartment [17] . In addition, dialysate bicarbonate was 40 mmol/l in our study compared to 30 mmol/l in the Dialysate composition was different with regard to glucose and bicarbonate concentrations. Whereas study reported by Dolson et al. High dialysate bicarbonate with increments in extracellular bicarbonate dialysate in the study of Dolson contained glucose at a concentration of 200 mg/100 ml, glucose-free dialysis concentration may contribute to intracellular potassium sequestration [18] . was delivered in our study. Thus, a major factor contributing to the distribution of potassium between
The current explanation for the reduction in dialysis efficiency as measured by urea kinetics using lowextracellular and intracellular compartments was different in these studies. With the delivery of glucose potassium dialysate is based on the regional blood flow model [19] . The delayed removal of solute from and the stimulation of insulin secretion, potassium is the body is mainly due to the low perfusion of the potassium-free dialysate is very effective for stable, non-diabetic patients treated for a duration of 4 h. locomotor system, which contains almost 80% of total body urea. Since urea transport can be assumed as Potassium removal during 0K was 117 mmol, compared to 78.5 mmol as published by others [6 ] . The flow limited, any increase in muscle blood flow will increase total body clearance and dialysis efficiency. difference can be explained by the lack of glucose dialysate, which tends to increase potassium removal And any impairment in muscle blood flow will lead to enhanced sequestration and delayed removal of urea [22] . We are willing to accept a more liberal food intake without strong potassium restriction in order to from this organ system. In the study of Dolson et al. the increase in dialysis efficiency as measured by urea obtain optimal nutritional parameters. Accordingly, our patients had a albumin level of 41.1±1.2 g/l in kinetics using a 3K dialysate bath was attributed to the vasodilatatory effect of potassium and to an the haemodiluted predialysis state. Potassium-free dialysis appears as an alternative for stable dialysis increased muscle blood flow. However, with the use of 11 mmol/l glucose in the dialysate, and with the stimu-patients without potassium dietary restriction and at risk of severe hyperkalaemia. Careful cardiological lation of insulin secretion it is likely that blood flow was also elevated in this study. Muscle blood flow is evaluation is recommended for those patients, since low potassium bath concentration may predispose higher with glucose administration and insulin secretion [20] . In our study one would expect a difference patients on digoxin therapy, or with left ventricular hypertrophy, to ventricular arrhythmias [23] . in urea removal between 0K and 2K baths with glucose-free dialysate as well. This was not the case.
This study was designed to evaluate the influence of dialysate potassium on urea removal and dose of With absence of insulin, muscle blood flow will be low at the beginning of dialysis and the effect of hypokala-dialysis. Both URR and single-pool Kt/V revealed no influence of dialysate potassium on dose of delivered emic vasoconstriction can be assumed to be minimal. The exact mechanism to explain the discrepancy in dialysis as measured by urea kinetics. The difference in equilibrated Kt/V between treatments analysed urea removal between the results reported by Dolson and our study remains speculative. It is very probable according to Eq. 2 was not significantly different from zero (H 0 =0). However, there was a trend for increased that dialysate glucose plays a key role in this question, especially when glucose concentration in dialysate is dose of dialysis measured by urea removal when increasing dialysate potassium. The analysis according high (11 mmol/l ). Studies to clarify the importance of dialysate glucose remain to be done in future.
to Eq. 2 is based on the assumption that urea generation rate was independent of dialysate potassium conUltrafiltration volumes were similar in both studies; however, ultrafiltration rates were 30% lower in this centration. This assumption is supported by the small contribution of urea generation rate to urea mass study because of the longer treatment times (4 vs 3 h). Thus intravascular volumes were probably higher, balance during dialysis. Only large variations in urea generation rate are expected to invalidate the calculaavoiding a critical reduction of the regional perfusion in this study. tion according to Eq. 2. Patients served as their own controls so that any possible difference in dialysis dose One of the goals of chronic HD is the removal of potassium that has accumulated in the body in the (DKt/V e ) should have produced a difference in solute removal. Even though the trends were in support of interval between two dialyses. The present study confirms the behaviour of potassium removal described the result reported by Dolson et al., the changes were far from significant. Therefore, the hypothesis that by others [21] . Plasma potassium concentration rapidly decreased during the first 60 min and stabilized during low-potassium dialysate baths reduce dialysis efficiency as measured by urea kinetics is not supported by our the last 60 min of dialysis. Plasma potassium reached a steady state during the last hour of dialysis, while data. As mentioned above, glucose and its indirect effect on regional blood flow distribution could play a potassium continued to emerge in the dialysate. Therefore it can be assumed that potassium removal key role in this question.
In conclusion, the present study demonstrates that rate was equal to the intra-to extracellular mass transfer rate. Although the rate of potassium removal potassium removal has no measurable influence on urea removal during high-flux, glucose-free, 40 mmol/l depends on the difference between plasma and dialysate potassium concentrations, the amount of potassium bicarbonate dialysis. In this setting, high potassium removal, when needed, does not significantly impair removed could not be predicted by the change in intradialytic plasma potassium concentrations using a dialysis efficiency based on urea kinetics. statistical model.
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tion of potassium removal on dialysis was found with the quantity of potassium originating in the intracellular space. In contrast to potassium, urea blood
